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Neuronal connectivity and specificity rely upon precise coordinated deploy-
ment of multiple cell-surface and secreted molecules. MicroRNAs have
tremendous potential for shaping neural circuitry by fine-tuning the spatio-
temporal expression of key synaptic effector molecules. The highly conserved
microRNA miR-8 is required during late stages of neuromuscular synapse
development in Drosophila. However, its role in initial synapse formation
was previously unknown. Detailed analysis of synaptogenesis in this system
now reveals that miR-8 is required at the earliest stages of muscle target con-
tact by RP3 motor axons. We find that the localization of multiple synaptic
cell adhesion molecules (CAMs) is dependent on the expression of miR-8,
suggesting that miR-8 regulates the initial assembly of synaptic sites. Using
stable isotope labelling in vivo and comparative mass spectrometry, we find
that miR-8 is required for normal expression of multiple proteins, including
theCAMsFasciclinIII(FasIII)andNeuroglian(Nrg).Geneticanalysissuggests
that Nrg and FasIII collaborate downstream of miR-8 to promote accurate
target recognition. Unlike the function of miR-8 at mature larval neuromuscu-
lar junctions, at the embryonic stage we find that miR-8 controls key effectors
on both sides of the synapse. MiR-8 controls multiple stages of synapse for-
mation through the coordinate regulation of both pre- and postsynaptic cell
adhesion proteins.
1. Introduction
Micro(mi)RNAs have emerged as versatile regulators of gene expression capable
of fine-tuning the expression patterns and levels of many proteins through mul-
tiple post-transcriptional mechanisms [1]. Sequence analysis of the expressed
genome in many metazoan species reveals hundreds of predicted mRNA targets
formiRNAregulation[2–6].Althoughbioinformatics alonecannotidentifyfunc-
tionally relevant miRNA targets, sequence analysis suggests that over 60% of
humanprotein-codinggenesareundersomedegreeofselectivepressuretomain-
tain pairing with miRNAs [7]. In addition to direct targeting of downstream
mRNAs, miRNA can control gene expression of secondary targets through mul-
tiple classes of intermediary regulators (i.e. transcription factors, RNA-binding
proteins, etc.). This suggests that a complex and potentially dynamic gene net-
work underlies the functions of many miRNAs. However, the identification
andinvivoanalysisofthefunctionallyrelevant targetgene networksorchestrated
and controlled by miRNAs remains a significant challenge in the field.
The striking expression of many miRNA in the nervous system [8–11] and an
earlywaveoffunctionalstudiesforahandfulofbrain-enrichedcandidates[12,13]
& 2014 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original
author and source are credited.revealthatmiRNAgenesparticipateintheformation,mainten-
ance and activity-dependent remodelling of synapses [14].
Prior to the onset of neural activity, axon guidance and synap-
togenesis follow stereotyped developmental programmes
that specify neuronal identity and establish chemical affin-
ity between synaptic partners through the control of gene
expression [15]. One excellent system with which to study the
relationship between genetic regulatory networks and synap-
togenesis is the developing neuromuscular junction (NMJ) of
Drosophila melanogaster (Drosophila). In Drosophila embryos
and larvae, each abdominal hemisegment of the animal con-
tains a stereotyped pattern of 30 muscles innervated by
approximately 34 motoneurons, each individually identifiable
byitssize,shapeandexpressionofmolecularmarkers[16–19].
A rich network of molecular pathways and cell-surface recep-
tors required for Drosophila NMJ formation, maintenance and
homeostasis has been defined bya community of investigators
[20–22], setting the stage for studying the layers of regulatory
mechanism that are required to achieve normal synapse
development in this system.
We recently identified the conserved Drosophila miRNA
miR-8 in a screen for modulators of a signalling pathway
that controls multiple phases of axon guidance and synapto-
genesis. At the mature larval NMJ, Drosophila miR-8 is
required for the morphological expansion of the synapse
required to match the substantial growth of target muscles
during larval development but is downregulated by synaptic
stimulation to allow activity-dependent synaptogenesis
[23–25]. Other studies of miR-8 and its vertebrate homol-
ogues (miR-141/200) showed that this conserved miRNA
family contributes to the regulation of diverse biological pro-
cesses from neurodegeneration, limb/wing patterning and
osmotic stress response to fat metabolism in the control of
body size [26–29]. In each of these contexts, one key target
gene was identified that could account for the majority of
miR-8 loss- orgain-of-functionmutantdefects.Here,weexam-
ined the role of miR-8 at early stages of NMJ development.
Combined with analysis of new downstream genes identified
through differential proteomic profiling of wild-type and
mutant tissue (see §3c), we find that miR-8 regulates an early
stage of synapse development via multiple downstream effec-
tor genes. Using stable isotope labelling and comparative mass
spectrometry, we found that miR-8 is required for embryonic
expression of the synaptic immunoglobulin superfamily cell
adhesion molecules (IgCAMs) Fasciclin III (FasIII) and Neuro-
glian (Nrg). We show that the deployment of FasIII and Nrg in
a subset of motor axons and their target muscles is dependent
on miR-8, suggesting that miR-8 regulates the initial assembly
of synaptic sites at the time of initial neuron-target muscle con-
tact.Finally,geneticanalysisintheDrosophilaembryosupports
a model where Nrg and FasIII cooperate to promote synapse
formation downstream of miR-8.
2. Material and methods
(a) Fly strains
We generated miR-8
D/D using FRT/FLP targeted deletion of
miR-8 flanked by PfXPgd01682 and PBacfWHgf05125 [30,31].
Two-sided PCR was used to isolate the recombinant, and gen-
omic PCR spanning the breakpoints confirmed the deletion.
ThegrossphenotypesofmiR-8
D/Dincludinglegandwingdefor-
mation as well as NMJ defects are comparable to another null
allele miR-8
D2 (a gift from S. Cohen, [23,26]). The following
nrg and fasIII alleles were used: nrg
14/FM7c (also known as
nrg
1) is a null, nrg
17/FM7c (also known as nrg
2)i sas t r o n g
hypomorph [32], and the amorphic fasIII
A142/CyO from the
Berkeley Drosophila Genome Project collection was inserted
by PBacf5HPwþg [33]. Lethal mutations/insertions were
keptoverFM7c,CyOandTM6BorTM3balancerchromosomes
that are additionally marked with twi-GAL4::UAS-EGFP, Dfd-
EYFP or wg-lacZ which express GFP, YFP or b-galactosidase
during embryogenesis to facilitate identification of embryos
harbouring homozygous mutant alleles. As wild-type controls,
strains isogenic w
1118and islet-t-mycGFP [34] were used. Fly
stocks Elav-GAL4, how
24B-GAL4, UAS-nrg
180, and all of those
mentioned above were obtained from Bloomington Drosophila
Stock Center and the Exelixis Collection at Harvard Medical
School. All strains were maintained and crossed at 258C.
(b) Immunohistochemistry and image analysis
Embryos were immunostained according to standard pro-
cedures [35], dissected and mounted in 70% glycerol (DIC)
or SlowFade Gold anti-fade reagent (Invitrogen). Primary
antibodies against the following molecules were used: mono-
clonal mouse anti-FasII (1D4, 1: 4), anti-FasIII (7G10, 1: 5),
anti-Nrg (BP104, 1:10) from Developmental Studies
Hybridoma Bank, Iowa City, USA (DSHB); rabbit anti-HRP
1:1500 (Jackson ImmunoResearch), rabbit anti-GFP 1: 500
(Abcam), rabbit b-galactosidase 1:5000 (Cappel). HRP-con-
jugated secondary antibodies were purchased from Jackson
ImmunoResearch; DAB Peroxidase Substrate Kit was from
Vector Labs; Alexa Fluor 488-, 546-conjugated secondary
antibodies and Alexa Fluor 633 phalloidin for muscle
F-actin staining were from Invitrogen.
DIC images were taken with 63  (1.4 N.A.) Plan Apochro-
mat objective (Nikon) in oil and a Spot camera mounted on a
Zeiss Axio Plan II microscope operated by Spot Imaging Sol-
ution software. Laser confocal images were acquired using
Nikon TE2000 with C1 point scanning and Zeiss LSM510
META confocal microscopes with 40  (0.95 N.A.) objective in
oil,1.5  digitalzoom,andshownasmaximalprojectionsofcon-
focal image stacks. We used the NIH ImageJ program to
measure axon length and compute synaptic coverage area
from confocal image stacks. For quantitative imaging analysis,
we used Alexa Fluorophores with excitation/emission charac-
teristics compatible with the wavelengths of lasers and META
spectral emission detectors installed in the Zeiss LSM510
system to minimize signal bleed-through between any two
channels from overlapping fluorescence emission spectra.
During image acquisition, we calibrated the settings to image
below the saturating level of fluorescence intensity across differ-
ent specimens and applied the same settings to pairs of
experiment and control genotypes. Quantification of immuno-
fluorescence was performed by integrating the mean signal
intensity within regions of interest that was identical in each
opticalsliceoverthethicknessofconfocalimagestacks.Wecom-
puted average values obtained from all embryos of the same
genotype onthe same slide and compared those values between
different genotypes prepared in parallel on the same day.
(c) DiI fill of RP3 motor neurons
Allembryoswereraisedat258C,dissectedonpoly-lysine-coated
coverslips at 15 h after egg laying (AEL) and fixed in 3.7% for-
maldehyde (less than 10 min). A total of 2 mg ml
21 DiI was
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2backfilledintosharpelectrodesandelectrodeshaftswerefurther
backfilledwith0.2 MLiCl.DiIwasinjectedintoRP3motorneur-
ons in abdominal segments A2–A6 by application of a
depolarizing current of 0.4–1 nA using an Iontophoretic Dye
Marker amplifier, D380 (Digitimer, UK). Muscles were perfo-
rated and counterstained with Alexa Fluor 647 phalloidin
overnight at 88C. Specimens were imaged with 63  (1.2 N.A.)
water immersion objective (Olympus) and a spinning disc
(CSU-22; Yokagawa) confocal field scanner mounted on an
Olympus BX51WI microscope, operated by Metamorph (7.1)
software (Molecular Devices). Optical slices were acquired at
300 nm intervals with effective pixel dimensions 210 nm  
210 nm controlled by a single objective Piezo drive (Physik
Instruments).
(d) In vivo SILAC
Five milligrammes of 0–10 h-old Drosophila embryos was col-
lected and transferred onto Whatman filter paper over a layer
of cotton to hatch in a humidity-saturated chamber at 258C.
The F1 larvae were fed with liquid fly food and fresh yeast
paste made from Lys
2/Arg
2 double auxotroph Saccharomyces
cerevisiae strain 3681 (gift from A. Rudner, University of
Ottawa) grown to saturation in lysine and arginine drop-out
YNB media (Difco) supplemented with either light isotope
L-lysine and L-arginine (Sigma) or heavy L-[
13C6]-lysine and
L-[
13C6]-arginine(CambridgeIsotopeLaboratories).Theculture
and labelling of yeast was carried out using the following pro-
cedures as described in [36]. Upon hatching, the F1 adult flies
were transferred to new egg-laying cages supplied with light
or heavy isotope labelled fresh yeast paste. Twenty milli-
grammes of F2 embryos was collected and homogenized in
RIPA buffer. Control and miR-8 mutant embryo lysates were
standardized using the Bradford assay (Pierce Biotechnology)
and combined at a 1:1 ratio using 150 mg protein from each
sample (300 mg total), boiled in SDS-PAGE sample buffer,
resolvedona4–15%Tris-glycinegelandstainedwithCoomas-
sie Blue (BioRad Laboratories). A single gel lane was excised,
divided vertically into 12 sections and each section excised
and subjected to in-gel trypsin digestion. The tryptic pep-
tides were extracted from the gel and analysed by liquid
chromatography tandem mass spectrometry followed by the
identification and quantification of peptides (see the electronic
supplementary material).
3. Results
(a) Genetic deletion of miR-8 causes subtle innervation
defects at the embryonic neuromuscular junction
We uncovered the miR-8 locus in a genetic screen for Abl tyro-
sine kinase modifier genes (C. S. Lu & D. Van Vactor 2009,
unpublished data) and showed that miR-8 promotes late
larval expansion of the NMJ via postsynaptic repression of the
actin-binding protein Enabled (Ena; [23]). However, the early
onset of miR-8 expression raised the question of whether this
miRNA might influence the initial stages of NMJ development.
Theprofile ofmiR-8 expression was previously characterized by
Northern blots of the major life cycle stages [37–39], indicating
that miR-8 expression begins during embryonic stages. We con-
firmed this result using a more sensitive quantitative RT-PCR
assay with greater temporal resolution (see the electronic sup-
plementary material) and discovered a major peak of miR-8 at
10.5–13h AEL as well as a minor peak at 20–22h AEL (elec-
tronic supplementary material, figure S1). Synaptogenesis at
the Drosophila NMJ starts at approximately 13 h AEL after
motor axon growth cones have contacted body wall muscles
and expanded filopodia to explore these [40,41]. During the
next 2 h of development, exuberant axonal arborizations over
non-targetmusclesarenormallywithdrawnandtheexploratory
membrane interfaces become restricted to specific synaptic sites
(target refinement stage at 13–15 h AEL; figure 1a). From 14 h
AEL onwards, postsynaptic specializations gradually accumu-
late glutamate receptors while synaptic vesicles accumulate at
nascent presynaptic active zones and individual synaptic
boutons appear [42,43].
A major peak of miR-8 expression conspicuously coin-
cides with the refinement of motor axon contacts with specific
target muscles. This prompted us to examine embryonic
NMJ morphology in mutants lacking miR-8. One of the best-
characterized groups of synapses in this system is a domain of
innervation formed by the intersegmental nerve branch b
(ISNb, a group of seven motor axons) on the ventral longi-
tudinal and oblique muscles (m6, m7, m13, m12 and m14.1,
m14.2, respectively; figure 1a,b). In wild-type embryos, as
inembryoshomozygousforamiR-8nullmutationgeneratedby
targeted deletion (see the electronic supplementary material,
figure S2), ISNb axons showed normal trajectories to reach
their ventral muscle target domain. However, subsequent to
the target recognition stage, we discovered an innervation
defect in the miR-8 null mutants. Using the IgCAM Fasciclin II
(FasII) as a marker for embryonic motor axons [44], we found
that the innervation of the cleft between m6 and m7 was
undetectable or the length substantially reduced in miR-8 null
embryos.TocompareexpressivityofdefectiveISNbinnervation
at m6/m7, the percentage of segments in which the anti-FasII
staining was less than half the length typical of wild-type
NMJs was quantified blind of genotype. In all miR-8 mutants
examined, approximately 50% of all A2–A7 hemiseg-
ments displayed this defect (figure 1c,d). The reduction of
FasIIstainingatthe m6/m7 muscle cleft was oftenaccompanied
byanincreaseinstainingatthemoredistalm13cleft.Toconfirm
that this phenotype was miR-8 specific, we compared miR-8
allelic combinations with controlsofnear identical genetic back-
ground where, instead of miR-8, the adjacent protein-coding
gene (CG6301) had been deleted (electronic supplementary
material, figure S2). While these control homozygous
CG6301D embryos showed no ISNb phenotype, we found that
even removal of one copy of miR-8 was sufficient to induce an
ISNb defect at an intermediate frequency (approx. 20%; figure
1d), suggesting a dose-dependent relationship between miR-8
and ISNb development. Because FasII localization to distinct
regions of the motor axon is regulated in the central nervous
system (CNS) [45–47], we also compared ISNb terminal mor-
phology in miR-8 nulls and isogenic controls using an
independent marker system (islet-GFP: tau-myc-EGFP under
control of islet regulatory regions [34]; figure 1e,f). The islet-
GFP marker revealed some degree of innervation at most m6/
m7 targets in miR-8 mutants. However, the synaptic contact as
assessed by integration of GFP intensity along the m6/m7
muscle cleft is reduced by nearly 40% compared with controls
(figure1g).ThisanalysisshowedthatalthoughFasIIlocalization
at the m6/m7 synaptic site was more severely affected than the
elaboration of motoraxon terminals, miR-8 is required from the
earliest stage of synapse formation, consistent with the early
miR-8 expression peak.
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3(b) Synaptic target recognition between RP3 motor
axon terminals and target muscles 6 and 7 is
affected by miR-8
One useful feature of the Drosophilasystem isthe extenttowhich
the identities of the motor neurons that make individual NMJs
have been defined. Motor neurons RP3 and RP5 innervate the
ventral muscles m6/m7 and of these RP3 is the first neuron to
form a functional synapse at this target. In order to determine
whether the defects in miR-8 mutant ISNb morphology
observed with FasII and islet-GFP represent a failure to assign
RP3 cell fate or an early defect in axon guidance, we performed
anterograde DiI injections. At 15 h AEL, RP3 motor neurons of
wild-type and miR-8 nullmutantembryosshowednormalmor-
phology of somata and dendritic arbors (not shown) and their
axon terminals successfully reached the m6/m7 cleft in all
cases (figure 2a,b; n ¼ 12 cases for wild-type and miR-8
D/miR-
8
D). However, in 15 h-old miR-8 mutants RP3 axon terminals
RP5 (all ventral)
entering ISNb motor axons
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Figure 1. miR-8 promotes embryonic motor axon ISNb innervation along muscle 6 and 7 cleft. (a) Schematic of the neuromuscular connectivity. The axons of motor
neurons (coloured circles) exit neuropile in the central nervous system (CNS) along three major nerve trunks: ISN, TN and SN which branch out further to innervate
dorsal, lateral and ventral muscle fields. Muscles are colour-matched with the representative examples of innervating motor neuron partners. ISNb branch (high-
lighted in bold), which consists of axons from motor neurons with distinct dendritic morphology, stereotypic orientation and position in relation to the anterior
commissures (AC), posterior commissures (PC) and longitudinal connectives in the ventral nerve chord, defasciculates from the ISN root to innervate ventral longi-
tudinal (pink shades) and oblique (yellow shades) muscles 6, 7, 12, 13, 14.1 and 14.2. RP3 motor neuron (highlighted in bold) specifically innervates muscles 6 and
7 (m6/m7) to form synapses. (b,c) Motor axon ISNb termini and innervation along m6/m7 cleft in stage 17 wild-type and miR-8
D/D mutant embryos by anti-FasII
immunostaining. Scale bar ¼ 10 mm. (b) Normal motor axon ISNb branching pattern and specific axon innervation along m6/m7 cleft (solid arrows) in isogenic
w
1118 embryos. (c) Motor axon ISNb branching pattern with weak innervation along m6/m7 cleft in miR-8
D/D mutant embryos (broken arrows). Weak innervation of
m6/m7 by the ISNb branch is characterized by the complete absence of anti-FasII immunoreactivity in situ in the most severe cases or otherwise by substantially
reduced length of axon innervation along m6/m7 cleft. The asterisk indicates the m13/m30 cleft with increased accumulation of FasII. (d) Quantification of the
frequency of ISNb innervation defect at m6/m7 cleft in wild-type and mutant embryos with genotypes as described in the bar graph. The frequency of defective
innervation is expressed as a percentage of affected hemisegments (n ¼ 180 for isogenic w1118; n ¼ 114 for miR-8
D/þ, n ¼ 285 for miR-8
D/D, n ¼ 164 for
CG6301
D/D, p ¼ 0.76   10
–4, one-way ANOVA). (e,f) ISNb axon termini and innervation along m6/m7 cleft in control stage 17 islet-t-mycGFP/þ (e; solid arrows)
and in miR-8
D/D; islet-t-mycGFP/þ mutant embryos (f; broken arrows) by anti-GFP immunostaining. Scale bar ¼ 10 mm. (g) Quantification of the reduced
synaptic coverage along m6/m7 cleft in islet-t-mycGFP/þ control and miR-8
D/D;islet-t-mycGFP/þ mutant embryos. Synaptic coverage is represented by inte-
gration of GFP immunofluorescence intensity along the m6/m7 cleft normalized to the signal intensity along the m12/m13 cleft, which is unaltered by miR-8
deletion and serves as the internal control (n ¼ 24; *p ¼ 5.48   10
–6, Student’s t-test).
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4did show two abnormalities: first, we noted a fourfold increase
inexuberantsproutingoffilopodiaandlesswell-definedelabor-
ation of the NMJ between m6/m7 (figure 2d,e); second, in
several instances RP3 axon terminals extended to a neighbour-
ing non-target muscle, m13, and formed varicosities on m13
(arrowheads in figure 2d; n ¼ 3 of 12). These observations are
consistent with both the decreased FasII staining at the m6/
m7 cleft and the increase in FasII labelling we found at m13 in
miR-8 null embryos (asterisk, figure 1c). Consistent with our
FasII and islet-GFP data, approximately 50% of the RP3 motor
axons manifested either reduced target innervation area and/
orincreasedexuberant sproutingoffilopodia.Theseresultscon-
firmed that loss of miR-8 had little effect on RP3 specification or
axonpathfindinginto thecorrect targetdomain.Rather,thefail-
ure of miR-8 mutants to restrict exploratory membrane contacts
and consolidate innervation at the m6/m7 synaptic site
suggested a role for miR-8 during the target refinement stage.
(c) A proteomic screen for miR-8 effectors in vivo
identifies functional clusters for synapse
development
Understanding the cellular mechanism(s) by which miR-8
promotes accurate innervation of m6/m7 required the identi-
fication of relevant downstream effector genes. Our previous
in silico (using TargetScan Fly 5.1) and expression analysis of
mRNAs to determine candidates that might be directly regu-
lated by miR-8, identified the actin-associated protein Ena as
a key effector that accounts for much of miR-8 NMJ function
at the larval stage [23]. However, to our surprise, both over-
expression assays and double-mutant genetic rescue assays
revealed that Ena cannot account for miR-8 function during
NMJ formation in the embryo (electronic supplementary
material, figure S3).
In order to define a more complete set of candidate
downstream effectors, we turned to a quantitative mass
spectrometry-based approach using an adaptation of SILAC
(Stable Isotope Labeling with Amino acids in Cell culture) for
use in whole animals [48–50]. We surveyed and compared
the proteomes directly from the wild-type and miR-8 null
embryos differentially labelled with
13Ca n d
15N on the Lys
and Arg residues (figure 3a).
13C-Lys/Arg provided unequivo-
cal differentiation between labelled peptides derived from the
same proteins but isolated from two different genetic back-
grounds (figure 3b,t o pp a n e l ) .T h i sd i f f e r e n t i a ll a b e l l i n g
workflowincludedautomaticquantificationofthepeptidemix-
turepriortotheidentificationoffragmentedpeptidestoconfirm
that98.5%ofheavy
13C-Lys/Arghadalreadybeenincorporated
in F1 generation adults (see §2d). We also found negligible con-
tribution of Arg to Pro conversion to the accuracy of
quantification. Quantifiable proteins in the miR-8 null and
wild-type distribute in a bell-shaped curve fitted to a normal
distribution along the log2 axis for the heavy (miR-8 null) rela-
tive to light (wild-type) ratios (figure 3b, bottom panel).
Approximately 95% of all quantifiable proteins cluster around
the population mean and hence we applied 2 s.d. as the cutoff
threshold to catalogue proteins with the most substantial
changes. We found 37 proteins with upregulation more than
180% and 48 proteins that were downregulated more than
55% in the absence of miR-8 (figure 3c).
To prioritize miR-8-dependent proteins that might con-
tribute to the miR-8 null embryonic phenotype, we
analysed the list of proteins with the highest differential
expression ratios from in vivo SILAC using a publically avail-
able DAVID functional pathway analysis and ontogeny tool
(electronic supplementary material). In contrast to the micro-
array profiling of potential targets of miR-8 which revealed
diverse functional classes with little class-specific enrichment
except for the ribosomal and translation process [26], this pro-
teomic strategy identified other functional clusters enriched
significantly above the background proteome based on one-
tailed Fisher exact probability of over-representation. Interest-
ingly, the top 10 most significant functional clusters of
proteins with altered expression in the miR-8 mutant
embryo, as compared to the background proteome, included
‘synapse organization and NMJ development’ (electronic
supplementary material, table S1).
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Figure 2. Synaptic target refinement is dependent on miR-8. (a) RP3 motor axon terminal (green) in a late stage 16 islet-t-mycGFP/þ control embryo at its target,
extending along the cleft between m6/m7 (red). RP3 motor neurons and axon terminals were labelled by anterograde DiI injection and muscles were counterstained
with Alexa Fluor 647 phalloidin. (b) Tracings of additional RP3 axon terminals in control embryos. (c) RP3 motor axon ISNb terminals reach muscle targets but are
not confined to the m6/m7 cleft in late stage 16 miR-8
D/D mutant embryos. The example here shows an RP3 motor axon process overextends to non-target muscle
m13, which is never observed in wild-type and control embryos at this stage. (d) Tracings of RP3 motor axon terminals in miR-8
D/D;islet-t-mycGFP/þ mutant
embryos that have exuberant sprouting of axonal processes (open arrowheads). Scale bar ¼ 10 mm. (e) Quantification of exuberant processes. An exuberant process
is characterized as a sprouting within the RP3 motor axon termini measured to be 10% or longer than the average length of the main branch. The number of
sproutings over a defined length of axon is used for comparison between control and mutant embryos (n ¼ 12; *p ¼ 2.92   10
–3, Student’s t-test).
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5(d) miR-8 is required for immunoglobulin superfamily
cell adhesion molecules Fasciclin III and Neuroglian
to localize to synaptic regions
Based on our characterization of miR-8 mutant defects in
synaptic innervation, we decided to investigate further how
miR-8 effects local synaptic adhesion. Within this class of
miR-8-dependent candidates, seven out of nine show various
neuroanatomy defective phenotypes when mutated and are
normally expressed in embryonic neurons and/or muscles
based on published literature and transcriptome analysis
performed by the Drosophila model organism Encyclopedia
of DNA Elements (modENCODE) project [51]. However,
these miR-8-dependent candidate effectors are not involved
in initiation of de novo synaptogenesis and lack seed sequence
homology to be direct targets of miR-8 (see the electronic sup-
plementary material and §2d). The fact that their levels
decrease in the miR-8 null background (electronic supplemen-
tary material, table S2) is consistent with miR-8 playing a role
in stabilizing target recognition during synapse development.
Among synaptic IgCAMs identified in our SILAC data-
set, two of them had been previously implicated in ISNb
development: FasIII [52,53] and Nrg [32,54]. In wild-type
embryos, FasIII is coordinately expressed on both the RP3
motor axon and at the specific central region of the m6/m7
muscle cleft where RP3 will form its synaptic terminal [55].
FasIII accumulates at the synaptic target site on m6/m7 even
when motor innervation is absent [56], suggesting that this
IgCAM accumulates due to homophillic contact on abutting
m6 and m7 membranes and thus presages the site of synaptic
contact. Although FasIII in miR-8 null showed a 58% reduction
relativetoinwild-typeinourSILACdataset,thiscouldreflectan
underestimate at synapses because FasIII expression in the
epidermis accounts for a major source [35], and these experi-
ments were performed with whole embryo lysates that cannot
distinguish between different sites of protein expression.
Thus, we examined the distribution of FasIII with in situ
immunocytochemistry. Consistent with the SILAC result, we
found a 34–65% decrease of anti-FasIII signal intensity in the
dorsal epidermal stripes of miR-8 null embryos (data not
shown). By contrast, RP3 motor axon expression of FasIII in
miR-8 nulls was indistinguishable from controls (figure 4a,b;
n ¼ 10),thusconfirmingthenormalcellfateandaxonpathfind-
ing of RP3 in these mutant embryos. The morphology and
unique peptides 20855
non-redundant peptides 18274
unique proteins 2872
SILAC benchmark from S2 cells 2450
quantifiable proteins 1228
false positive rate proteins 6.8%
false positive rate peptides 0.6%
minimal peptide length (aa) 8
upregulated (p<1.5×10 –7)* 37
downregulated (p<0.05)* 48
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Figure 3. Profiling in vivo gene effectors downstream of miR-8 by comparative proteomics. (a) Schematic work flow for the metabolic labelling of essential amino
acids lysine and arginine for all proteins in intact Drosophila (‘in vivo SILAC’). ‘Light’
12C6
14N2 L-lysine and L-arginine or ‘heavy’
13C6
15N2 L-lysine and L-arginine with a
predicted mass shift in daltons from Lys (0), Arg (0) to Lys (þ8) and Arg(þ10) were added to the drop-out media to grow a Lys, Arg double auxotroph S. cerevisiae
strain to saturation. Aliquots of yeast culture were fed as the food source to wild-type isogenic w
1118 and miR-8
D/D mutant embryos from 10 h AEL on for one
generation at 258C. Proteins from whole cell extracts (WCE) of native fly tissues were resolved by SDS-PAGE and digested by trypsin to release peptide mixtures
containing labelled Lys and Arg in the C-terminus for further quantification. (b) Quantification of peptide abundance and relative ratio of heavy (H: miR-8
D/D)t o
light (L: w
1118) by liquid chromatography and tandem mass spectrometry (LC-MS/MS). In the top panel, the illustration depicts unambiguous separation of peptide
clusters on MS spectra for proteins labelled with heavy Lys and Arg and the light isotopes thanks to a sizable shift in relative molecular mass. Abundance is
measured by peak amplitudes of the labelled and label-free peptides on MS spectra. Peptide identification is conducted from pattern recognition searches between
composite peptide reference MS/MS databases and experimental MS/MS spectra. In the bottom panel, the distribution of quantifiable proteins are plotted as a
histogram of log2-fold changes in H/L ratio indicating the relative expression levels of proteins found in the labelled miR-8
D/D mutant and the
1118 embryos. (c)
Summary table of key statistics for the comparative proteomic profiling using SILAC fly embryos.
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6positionoftheventralmusclesinmiR-8 mutantswasalsoindis-
tinguishable from wild-type. However, when we examined
FasIII accumulation on the adjoining surfaces of m6 and m7,
it was absent or barely detectable in 67% of hemisegments
of all miR-8 mutant embryos examined (n ¼ 8, figure 4c,d).
This striking change of FasIII expression at m6/m7 in miR-8
mutants validated postsynaptic FasIII as a factor downstream
of miR-8, and suggested that miR-8 is required to define the
synaptic site to which RP3 growth cones are attracted during
motor axon targeting.
Based on the coordinated pre- and postsynaptic pattern of
FasIII expression at the m6/m7 embryonic NMJ, Chiba and
colleagues proposed that FasIII directs RP3 target selection,
basedonevidence ofalteredRP3targetingupon misexpression
of FasIII on non-target ventral muscles [52]. However, FasIII
lossoffunctionalonedidnotchangethesiteofRP3innervation
[52], suggesting that additional cell-surface proteins contribute
to precise target recognition at the m6/m7 cleft. In this regard,
Nrg was a promising candidate due to its expression on ISNb
motor growth cones and ISNb axon phenotypes observed in
nrg mutants [32]. Nrg is the Drosophila orthologue of the
neural IgCAM L1, the causal factor for multiple neurological
defectsassociatedwithCRASHsyndromepatients(Corpuscal-
losum hypoplasia, Retardation, Adducted thumbs, Spasticity
Nrg
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Figure 4. miR-8affectsinsitu expressionof IgCAMs FasIIIandNrgin primordial synapses.(a–d) Anti-FasIIIimmunohistochemistryintheCNS and musclesm6/m7 cleft
of stage 16 embryos. FasIII is expressed in RP3 motor neurons in theneuropile (asterisks) andtheiraxons (arrows)in both (a) wild-typew
1118 and (B)miR-8
D/D mutant.
(c) FasIII immunostaining along m6/m7 cleft is present in wild-type at this stage (solid arrow). (d) Reduced FasIII immunostaining along m6/m7 cleft (broken arrow) in
miR-8
D/D mutant. Scale bar ¼ 10 mm. (e–h) Anti-Nrg immunohistochemistry (green) in the CNS and ISNb motor axon targeting domain in early stage 16 embryos.
Anti-HRP(red) counterstainstheneuronal cell bodiesandprocesses intheCNS(e,f) and phalloidincounterstains muscle actin (blue)in(g,h).(e) CNS expressionof Nrg in
motorneurons,includingRP3sintheboxregion(asterisks)isvisibleinthemostinternalfocalplanesoftheventralnervechord,andinlongitudinalandcommissuralaxon
tracts (arrows) of wild-typew
1118 embryos. The Nrg isoform expressed in the cellmembrane of epidermal cells is visible in the superficial focal planes. (f) Decreased Nrg
immunostaining signal in the CNS of miR-8
D/D mutant embryos. Outlines of RP3s inside the box region are highlighted with dotted lines and axon tracks indicated by
arrows.(g)AccumulationofNrgimmunostainingintheISNbmotoraxon(green)innervationsinthetargetventralmusclesdomain(blue)inwild-typew
1118embryos.(g’)
View of the boxed region in (g) in greater detail. Filopodial tips of ISNb growth cones (asterisks) and peripheral axons (arrows) are indicated. (h) Decreased Nrg accumu-
lation in the ISNb motoraxon (green) in miR-8
D/D mutant embryos. Growth cones (asterisks) and peripheral axons (arrows) in miR-8
D/D mutant embryos are indicated.
(h’) View of the boxed region in (h) with higher magnification. Scale bar ¼ 10 mm. (i) Summary diagram of Nrg expression in the CNS and ISNb axons.
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7and Hydrocephalus) [57]. The overall expression of Nrg was
decreased to 58% in miR-8 null embryos when compared
with wild-type controls in our SILAC dataset (electronic sup-
plementary material, table S2). Two distinct Drosophila Nrg
isoforms are expressed in embryo: Nrg
167 is ubiquitous, while
Nrg
180 is neuronal-specific [58]. We characterized spatial
changes in Nrg
180 by in situ by immunocytochemistry in
wild-type and miR-8 null embryos. In the ventral nerve cord,
loss of miR-8 leads to a reproducible decrease in anti-Nrg
signal in the longitudinal connectives, anterior and posterior
commissures, and in multiple neurons including RP3 located
in the neuropile, as compared to wild-type controls (arrows
and box insert in figure 4e,f; i (top panel); n ¼ 12; see §2b). In
the periphery, Nrg normally accumulates along peripheral
nerves (figure 4g and arrow in figure 4g’) and on the filopodia
of wild-type ISNb motor growth cones as they explore the ven-
tralmusclefield(asterisksinfigure 4g’). However, inmiR-8 null
mutant embryos, Nrg levels on these ISNb growth cones are
substantially decreased (n ¼ 7, figure 4h and asterisks in
figure 4h’) and 72% of hemi-segments analysed showed at
least a 30% reduction. This decrease in Nrg levels on motor
axon growth cones as they explore their target area occurs
locally, as intersegmental axons on their trajectory towards
dorsal muscle targets showed levels of Nrg that were indistin-
guishable from controls (see arrows in figure 4g’,h’). These
observationsconfirmedthatnormalexpressionandlocalization
of neuronal Nrg require miR-8.
(e) Presynaptic Neuroglian acts downstream of miR-8
and genetically interacts with Fasciclin III
LikeitshumancounterpartL1-CAM[59],Nrgisrequiredforthe
accurate connectivity of multiple axons in Drosophila.I nt h e
adult fly, loss or mutation of Nrg protein leadsto reduced num-
bers of axonal terminals forming synapses in visual and escape
reflex circuits [60,61]. Nrg isalso essential formaintainingstable
synaptic architecture at larval NMJs [62]. However, in embryos,
Nrg has been shown to support ISNb motoraxon guidance and
targeting [32]. Next, wewanted to determinethe functional con-
tribution of the miR-8 downstream effectors, Nrg and FasIII, to
the formation of NMJs in the embryo. Using anti-FasII staining
of stage 17 motor axons, we applied the same parameters as
described for figure 1d and quantified the frequency of dimin-
ished or absent innervations at the m6/m7 cleft. We found
that two different nrg alleles (nrg
14 and nrg
17)d i s p l a yas y n a p t i c
defect highly reminiscent of that observed in the miR-8 null,
though with reduced penetrance (figure 5b,c). If lower levels
of Nrg on ISNb growth cones were responsible for the miR-8
NMJ phenotype, we reasoned that elevation of Nrg (with
UAS-nrg) in embryos lacking miR-8 should compensate and
restore innervation of the m6/m7 cleft. While neural-specific
elevation of Nrg expression using an Elav-GAL4 driver did not
generate any ISNb defect on its own (not shown), it restored
66.7% of weak synaptic contacts in a miR-8 null background
(figure 5d), thus supporting a model where miR-8 promotes
ISNb NMJ formation at m6/m7 by maintaining levels of Nrg
inthesemotoraxongrowthconesastheyexploretheirtargetter-
ritory.Toconfirmthepresynaptic specificityofNrgfunction,we
also examined the impact of Nrg over-expression on the target
muscle cells (using how
24B-GAL4). In contrast to neuronal
expression, elevation of Nrg in muscles induced a de novo
ISNb axon arrest phenotype (not shown). Postsynaptic
expression of UAS-nrg in the miR-8 null suppressed only 10%
of the innervation defect at m6/m7 in the sub-population of
motor axons that reach the target domain (figure 5d). Thus,
we concluded that mainly changes in presynaptic Nrg
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Figure 5. Trans-synapticcoordinationofNrgwithFasIIIdownstreamofmiR-8is
essential for robust ISNb motor axon innervations at m6/m7. (a) Normal ISNb
branching pattern and specific innervation along m6/m7 cleft (solid arrows) as
revealed by anti-FasII immunostaining in stage 17 wild-type w
1118 embryos.
(b) Weak ISNb innervations similar to those observed in miR-8
D/D mutant
embryos (broken arrow) and normal innervations (solid arrow) along m6/m7
cleft in the adjacent hemisegments of a loss-of-function nrg
14 mutant
embryo. Scale bar ¼ 10 mm. (c) Quantification of the frequencyof ISNb inner-
vation defect along m6/m7 cleft in wild-type, miR-8
D/D, and nrg mutant
embryos (n ¼ 180 for w
1118; n ¼ 285 for miR-8
D/D; n ¼ 136 for
nrg
14/nrg
14; n ¼ 100 for nrg
17/nrg
17). The homozygous or hemizygous nrg
14
and nrg
17 are not significantly different from each other (p ¼ 0.172, Student’s
t-test). (d) Quantification of the pre- and postsynaptic rescue by full-length
Nrg transgene UAS-Nrg
180 in the miR-8
D/D background (n ¼ 180 for isogenic
w
1118;n ¼ 285formiR-8
D/D;n ¼ 149formiR-8
D/D;Elav . UAS-Nrg, **p ¼
1.42   10
–8, Students t-test; n ¼ 96 for miR-8
D/D;how
24B . UAS-Nrg;
*p ¼ 0.003, Student’s t-test). (e) Quantification of the genetic interaction
between Nrg (nrg
14) and FasIII (fas3
A142). n ¼ 180 for w
1118; n ¼ 285 for
miR-8
D/D; n ¼ 136 for nrg
14/nrg
14; n ¼ 120 for fas3
A142; n ¼ 118 for
nrg
14/nrg
14;fas3
A142/fas3
A142. The percentage of weak m6/m7 innervation in
thenrg;fas3doublemutant iscomparable tothatof miR-8
D/Dmutantembryos
(p ¼ 0.384, Student’s t-test).
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8expression contributeto the ISNbphenotypeobserved inmiR-8
null mutant embryos.
While NMJ formation at the m6/m7 synaptic site requires
Nrg, the fact that strong nrg alleles display roughly half the
penetrance of miR-8 nulls for this phenotype suggested that
some additional effector(s) were involved. Given the striking
change in synaptic FasIII accumulation in miR-8 mutants
(figure 4d), we wondered whether the combined influence of
Nrg and FasIII might explain the higher penetrance of the
miR-8 mutant phenotype, even though elimination of FasIII
aloneisnotsufficienttoinducethedefect.Totestthispossibility,
we genetically removed both FasIII and Nrg at the same time
and then quantified the m6/m7 innervation using anti-FasII
staining. Interestingly, introduction of a FasIII null allele (fas-
III
A142, which has no ISNb phenotype alone) into an nrg
14/
nrg
14 mutant background more than doubled the frequency of
m6/m7 innervation defects, as compared to embryos singly
mutantfornrg
14(figure5e).Thefactthatthem6/m7innervation
phenotype in nrg
14/nrg
14;fasIII
A142/fasIII
A142 double-mutant
embryos matches the strength and penetrance of the defects
found in miR-8 homozygous nulls is consistent with a model
where a combination of pre- and postsynaptic IgCAMs are
key downstream effectors of miR-8 for NMJ formation.
4. Discussion
Although miRNAs hold substantial promise as regulators of
synapse development, maintenance and plasticity, very little
is known about the roles of particular miRNA genes in match-
ing axon terminals with appropriate synaptic partners in the
embryonic nervous system. Our findings identify a novel role
for miR-8 during the refinement of initial synaptic contacts in
the Drosophila embryo. Through a combination of comparative
quantitative proteomics and developmental genetic analysis,
we find that miR-8-dependent expression of the synaptic
CAMs Nrg and FasIII can account for the abnormal behaviour
of RP3 motor neuron synaptic terminals in miR-8 mutants.
Unlike late larval stages where only we find evidence for
postsynaptic miR-8 control of NMJ morphogenesis [23], pre-
synaptic sequestration of embryonic miR-8 moderately
increases the frequency of innervation defects of ISNb axon
along m6/m7 (electronic supplementary material, figure S4)
and is required for normal localization of Nrg on ISNb motor
growth cones. Since embryonic miR-8 also is required for
deployment of FasIII in the specific region of m6/m7 cleft nor-
mally innervated by ISNb, we propose that miR-8 acts to
coordinate synaptic CAMs on both sides of the synapse.
The targeting ofmotoraxonsto theirrespective muscle part-
ners in Drosophila has been mapped at single cell resolution,
revealingaremarkablyspecificandstereotypedpatternofinner-
vation. To provide sufficient information content for robust and
specific target recognition, popular models often rely on a com-
binatorialcodeofmanycell-surfaceproteins,includingIgCAMs,
leucine-rich repeat adhesionmolecules (LRRs) andreceptors for
diffusible cues (e.g. Wnt, Netrin, Semaphorins). However, such
modelshaveproveddifficulttovalidateinvivo.P r e v io u se x p e r i-
ments with the diffusible Semaphorin II (Sema II) and Netrin
during RP3 innervation of m6/m7 did suggest a combinatoral
mechanism [63], but functional synergy between these secreted
factors was only observed via Sema II misexpression. While
combinatorial target specification had not been previously
tested for synaptic CAMs in Drosophila, our current data
demonstrate combinatorial synergy between Nrg and FasIII at
the m6/m7 NMJ via loss of endogenous gene function. During
this stage, miR-8 appears to play a rather subtle role in refining
the target recognition of motor axon terminals at the m6/m7
cleft by regulating the spatial distribution of Nrg and FasIII.
While additional experiments will be necessary to prove that
miR-8 function at the m6/m7 NMJ can be fully accounted for
by Nrg and FasIII, the nature of this early phenotype suggests
that miR-8 contributes to the accuracy or robustness of motor
connectivity, consistent with the roles of many miRNAs in
fine-tuning of genetic circuits [64].
I ti st h o u g h tt h a tas e to fn e u r o n a la n dm u s c l et r a n s c r i p -
tion factors determines the deployment of genes required to
achieve accurate connectivity in the neuromuscular system [65],
althoughthepreciserelationshipbetweenthetargetingreceptors
and the upstream factors that control their expression is just
beginning to emerge. For example, the transcription factor Tey
h a sb e e np r o p o s e da sat a r g e t i n gf a c t o ri nm 1 2v i ar e p r e s s i o n
of the repellent cell-surface protein Toll [66]. Because neither
the Nrg nor FasIII gene contains sites with homology to the
miR-8 seed sequence complement, and because the levels of
these synaptic IgCAMs are decreased in miR-8 mutants, we
believe that miR-8 controls Nrg and FasIII via some intermediate
regulatory component(s). While the transcription factors
upstream of FasIII haveyet to be defined, genetic studies suggest
that neuronal Nrg expression falls under the negative regulation
ofthehomeoboxproteinEngrailed(En,[67]).WhenEnisoverex-
pressed in all post-mitotic neurons, Nrg immunostaining in the
embryonic CNS, sensory and motor axon pathways including
RP3 all decreased [67]. In addition, the 30-UTR of the en mRNA
contains one seed sequence homology site for miR-8 that is
well conserved across Drosophilid species (not shown). Whether
EnservesasanintermediatebetweenmiR-8andfunctionaleffec-
tor proteins in the embryonic nervous system will require careful
quantitative analysis of En expression in miR-8 mutants, plus
additional in vitro and in vivo functional validation.
RecentworkhasbeguntosuggestrolesformiRNAfunction
in axon growth and guidance [68–70] in addition to a larger
body of work on miRNA regulation of dendritic development
and synapse plasticity [12]. However, little is known about
miRNA controloftheinitial formationand specificityofsynap-
tic connectivity. Our studies of miR-8 and two downstream
synaptic IgCAMs suggest that miRNA can coordinately regu-
late pre- and postsynaptic effector molecules. Our data also
indicate that Nrg and FasIII act synergistically to ensure
robust synaptogenesis in vivo, providing evidence for
combinatorial specification of synaptic connectivity.
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